Total Payments
$15,647
2024 Payments
$680.39
Companies
39
Transactions
707
Medicare Patients
8,201
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$15,577 (99.6%)
Education$69.67 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,577 | 695 | 99.6% |
| Education | $69.67 | 12 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $2,878 | 91 | $0 (2024) |
| Amgen Inc. | $1,779 | 80 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,738 | 87 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,063 | 42 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,017 | 47 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $955.67 | 50 | $0 (2024) |
| PFIZER INC. | $902.25 | 44 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $667.39 | 22 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $596.33 | 27 | $0 (2022) |
| AbbVie Inc. | $502.25 | 27 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $680.39 | 30 | Novartis Pharmaceuticals Corporation ($158.27) |
| 2023 | $1,410 | 43 | Janssen Pharmaceuticals, Inc ($411.16) |
| 2022 | $1,679 | 75 | Janssen Pharmaceuticals, Inc ($378.03) |
| 2021 | $1,790 | 88 | Janssen Pharmaceuticals, Inc ($407.89) |
| 2020 | $1,210 | 57 | Janssen Pharmaceuticals, Inc ($251.22) |
| 2019 | $2,495 | 114 | Janssen Pharmaceuticals, Inc ($528.84) |
| 2018 | $3,088 | 144 | Amgen Inc. ($481.39) |
| 2017 | $3,294 | 156 | Janssen Pharmaceuticals, Inc ($480.14) |
All Payment Transactions
707 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Bone Health | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $28.19 | General |
| Category: Cardiovascular | ||||||
| 11/11/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: DIABETES | ||||||
| 10/25/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Bone Health | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: DIABETES | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $30.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/05/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/05/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $13.81 | General |
| Category: Coronary | ||||||
| 06/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Cardiology | ||||||
| 06/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: RESPIRATORY | ||||||
| 05/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: DIABETES | ||||||
| 05/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $32.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Cardiology | ||||||
| 04/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $32.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/25/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,930 | 3,606 | $1.6M | $213,635 |
| 2022 | 21 | 2,005 | 4,195 | $1.6M | $237,186 |
| 2021 | 16 | 2,187 | 4,752 | $2.1M | $299,454 |
| 2020 | 19 | 2,079 | 4,310 | $2.0M | $256,408 |
Total Patients
8,201
Total Services
16,863
Medicare Billing
$1.0M
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 367 | 859 | $17,180 | $2,577 | 15.0% |
| 93308 | Follow-up or limited ultrasound examination of heart | Office | 2021 | 21 | 26 | $24,440 | $2,342 | 9.6% |
| 93228 | Heart rhythm tracing, computer analysis, and interpretation of patient-triggered events greater than 24-hour ekg up to 30 days | Office | 2021 | 55 | 56 | $24,640 | $1,370 | 5.6% |
| 93979 | Ultrasound scan of blood flow of aorta, vena cava, bypass graphs, or one side of the groin or limited scan | Office | 2021 | 12 | 12 | $10,896 | $1,331 | 12.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 346 | 959 | $359,625 | $62,768 | 17.5% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 260 | 273 | $520,511 | $47,670 | 9.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 249 | 485 | $266,750 | $47,545 | 17.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 443 | 1,450 | $210,250 | $22,808 | 10.8% |
| 93975 | Ultrasound scan of abdominal, pelvic, and/or scrotal arterial inflow and venous outflow | Office | 2020 | 49 | 49 | $121,177 | $13,025 | 10.7% |
| 93970 | Ultrasound scan of veins of both arms or legs including assessment of compression and functional maneuvers | Office | 2020 | 57 | 60 | $104,334 | $11,394 | 10.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 64 | 64 | $54,400 | $9,700 | 17.8% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2020 | 49 | 49 | $85,344 | $9,177 | 10.8% |
| 93925 | Ultrasound study of arteries and arterial grafts of both legs | Office | 2020 | 35 | 35 | $71,865 | $8,754 | 12.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 43 | 54 | $40,230 | $6,934 | 17.2% |
| 93268 | Heart rhythm symptom-related tracing and interpretation of 24-hour ekg monitoring up to 30 days | Office | 2020 | 21 | 21 | $42,630 | $4,144 | 9.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 19 | 19 | $20,235 | $3,532 | 17.5% |
| 93308 | Follow-up or limited ultrasound examination of heart | Office | 2020 | 22 | 27 | $25,380 | $2,560 | 10.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 333 | 667 | $13,340 | $1,990 | 14.9% |
| 93224 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg | Office | 2020 | 18 | 18 | $21,420 | $1,424 | 6.6% |
| 93979 | Ultrasound scan of blood flow of aorta, vena cava, bypass graphs, or one side of the groin or limited scan | Office | 2020 | 11 | 11 | $9,988 | $1,230 | 12.3% |
| 93228 | Heart rhythm tracing, computer analysis, and interpretation of patient-triggered events greater than 24-hour ekg up to 30 days | Office | 2020 | 36 | 37 | $16,280 | $941.00 | 5.8% |
| 93321 | Follow-up or limited heart doppler ultrasound study of heart blood flow, valves, and chambers | Office | 2020 | 12 | 16 | $11,200 | $420.96 | 3.8% |
| 93325 | Doppler ultrasound study of color-directed heart blood flow, rate, and valve function | Office | 2020 | 12 | 16 | $14,560 | $393.12 | 2.7% |
About Dr. Leonid Chernov, M.D
Dr. Leonid Chernov, M.D is a Cardiovascular Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1902801145.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leonid Chernov, M.D has received a total of $15,647 in payments from pharmaceutical and medical device companies, with $680.39 received in 2024. These payments were reported across 707 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($15,577).
As a Medicare-enrolled provider, Chernov has provided services to 8,201 Medicare beneficiaries, totaling 16,863 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Brooklyn, NY
- Active Since 06/15/2005
- Last Updated 03/08/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1902801145
Products in Payments
- XARELTO (Drug) $2,584
- ENTRESTO (Drug) $1,113
- ELIQUIS (Drug) $1,067
- Repatha (Biological) $1,049
- JARDIANCE (Drug) $856.02
- LEQVIO (Drug) $625.21
- VERQUVO (Drug) $609.33
- Vascepa (Drug) $480.92
- FARXIGA (Drug) $442.84
- PRALUENT (Drug) $433.14
- BRILINTA (Drug) $384.19
- JANUVIA (Drug) $354.36
- Veltassa (Drug) $350.76
- PRALUENT ALIROCUMAB INJECTION (Biological) $340.68
- Corlanor (Drug) $334.67
- INVOKANA (Drug) $306.78
- Kerendia (Drug) $296.35
- PRADAXA (Drug) $294.04
- PRALUENT (Biological) $255.65
- CHANTIX (Drug) $231.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Brooklyn
Dr. Felix Yang, M.d, M.D
Cardiovascular Disease — Payments: $599,451
Cardiovascular Disease $599,451
Ozgen Dogan, Md, MD
Cardiovascular Disease — Payments: $367,116
Cardiovascular Disease $367,116
Dr. Adam Budzikowski, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $346,063
Cardiovascular Disease $346,063
Dr. Peter Rouvelas, M.d, M.D
Cardiovascular Disease — Payments: $339,378
Cardiovascular Disease $339,378
Dr. Ronald Wharton, M.d, M.D
Cardiovascular Disease — Payments: $298,083
Cardiovascular Disease $298,083
Dr. Sorin Brener, Md, MD
Cardiovascular Disease — Payments: $225,799
Cardiovascular Disease $225,799